DE602004027808D1 - Tablette enthaltend fluvastatin und calciumcarmellose - Google Patents

Tablette enthaltend fluvastatin und calciumcarmellose

Info

Publication number
DE602004027808D1
DE602004027808D1 DE602004027808T DE602004027808T DE602004027808D1 DE 602004027808 D1 DE602004027808 D1 DE 602004027808D1 DE 602004027808 T DE602004027808 T DE 602004027808T DE 602004027808 T DE602004027808 T DE 602004027808T DE 602004027808 D1 DE602004027808 D1 DE 602004027808D1
Authority
DE
Germany
Prior art keywords
carcellosis
calcium
tablet containing
fluvastatin
containing fluvastatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004027808T
Other languages
English (en)
Inventor
Tomoyuki Uehara
Kenji Taguchi
Kenichi Kitaoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE602004027808D1 publication Critical patent/DE602004027808D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602004027808T 2003-06-25 2004-06-24 Tablette enthaltend fluvastatin und calciumcarmellose Expired - Fee Related DE602004027808D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25
PCT/EP2004/006865 WO2005000276A1 (en) 2003-06-25 2004-06-24 Tablet comprising fluvastatin and carmellose calcium

Publications (1)

Publication Number Publication Date
DE602004027808D1 true DE602004027808D1 (de) 2010-08-05

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027808T Expired - Fee Related DE602004027808D1 (de) 2003-06-25 2004-06-24 Tablette enthaltend fluvastatin und calciumcarmellose

Country Status (21)

Country Link
US (1) US20090117181A1 (de)
EP (1) EP1641440B1 (de)
KR (1) KR20060030480A (de)
CN (1) CN1809342A (de)
AT (1) ATE471713T1 (de)
AU (1) AU2004251439B2 (de)
BR (1) BRPI0411855A (de)
CA (1) CA2529447A1 (de)
CO (1) CO5650224A2 (de)
DE (1) DE602004027808D1 (de)
EC (1) ECSP056238A (de)
IL (1) IL172531A0 (de)
IS (1) IS8249A (de)
MA (1) MA27889A1 (de)
MX (1) MXPA05013943A (de)
NO (1) NO20060261L (de)
NZ (1) NZ544119A (de)
RU (1) RU2361582C2 (de)
TN (1) TNSN05330A1 (de)
WO (1) WO2005000276A1 (de)
ZA (1) ZA200509930B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101426478A (zh) * 2006-02-24 2009-05-06 特瓦制药工业有限公司 氟伐他汀钠药物组合物
WO2012049156A1 (en) * 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
WO2012141160A1 (ja) 2011-04-12 2012-10-18 沢井製薬株式会社 ピタバスタチン含有製剤及びその製造方法
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) * 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
AU2001232244A1 (en) * 2000-02-10 2001-08-20 Takeda Chemical Industries Ltd. Drug comprising combination
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
AU2001294192A1 (en) * 2000-10-06 2002-04-22 Takeda Chemical Industries Ltd. Solid preparations

Also Published As

Publication number Publication date
CA2529447A1 (en) 2005-01-06
IS8249A (is) 2006-01-20
ZA200509930B (en) 2007-01-31
AU2004251439B2 (en) 2008-09-11
NO20060261L (no) 2006-01-18
EP1641440A1 (de) 2006-04-05
IL172531A0 (en) 2006-04-10
TNSN05330A1 (en) 2007-07-10
KR20060030480A (ko) 2006-04-10
AU2004251439A1 (en) 2005-01-06
RU2361582C2 (ru) 2009-07-20
EP1641440B1 (de) 2010-06-23
BRPI0411855A (pt) 2006-08-29
ATE471713T1 (de) 2010-07-15
MA27889A1 (fr) 2006-05-02
MXPA05013943A (es) 2006-02-24
US20090117181A1 (en) 2009-05-07
WO2005000276A1 (en) 2005-01-06
CO5650224A2 (es) 2006-06-30
NZ544119A (en) 2008-04-30
RU2006101889A (ru) 2007-08-10
CN1809342A (zh) 2006-07-26
ECSP056238A (es) 2006-04-19

Similar Documents

Publication Publication Date Title
NO20052309D0 (no) Nutrasoytisk mangostanblanding.
CR7076S (es) Recipiente
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20060261L (no) Tablett omfattende fluvastatin og karmellose kalsium
NO20041195L (no) Tablettmater.
ZA200604874B (en) Pharmaceutical compositions
SE0301650D0 (sv) Novel compounds
SI1729794T1 (sl) Farmacevtski pripravek, ki vsebuje sulfobetain, ki nima lastnosti detergenta
ZA200408787B (en) Pharmaceutical combination.
ITFI20020246A1 (it) Contenitore sterile.
NL1025055A1 (nl) Verbeterd lampontwerp.
ES1052333Y (es) Cajon premarco.
ES1051309Y (es) Desmenuzador de especias.
NL1024812A1 (nl) Lampenkap.
ES1055913Y (es) Linterna.
ES1053557Y (es) Luminaria vertical empotrable.
ES1053421Y (es) Linterna.
SE0202435D0 (sv) Lykta, särskilt gravlykta
ES1053053Y (es) Destoconador vertical.
ES1052719Y (es) Lampara dinamica.
ES1052131Y (es) Luminaria estanca mejorada.
ITSS20020004A1 (it) Paella algherese.
ZA200209660B (en) Lamp.
ES1053652Y (es) Luminaria empotrable.
ES1052229Y (es) Base de andamio.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee